1. Home
  2. COHN vs ICU Comparison

COHN vs ICU Comparison

Compare COHN & ICU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COHN
  • ICU
  • Stock Information
  • Founded
  • COHN 1999
  • ICU 2018
  • Country
  • COHN United States
  • ICU United States
  • Employees
  • COHN N/A
  • ICU N/A
  • Industry
  • COHN Investment Bankers/Brokers/Service
  • ICU Biotechnology: Pharmaceutical Preparations
  • Sector
  • COHN Finance
  • ICU Health Care
  • Exchange
  • COHN Nasdaq
  • ICU Nasdaq
  • Market Cap
  • COHN 21.6M
  • ICU 20.3M
  • IPO Year
  • COHN N/A
  • ICU N/A
  • Fundamental
  • Price
  • COHN $12.59
  • ICU $0.80
  • Analyst Decision
  • COHN
  • ICU
  • Analyst Count
  • COHN 0
  • ICU 0
  • Target Price
  • COHN N/A
  • ICU N/A
  • AVG Volume (30 Days)
  • COHN 11.4K
  • ICU 4.1M
  • Earning Date
  • COHN 07-31-2025
  • ICU 08-13-2025
  • Dividend Yield
  • COHN 7.94%
  • ICU N/A
  • EPS Growth
  • COHN 37.63
  • ICU N/A
  • EPS
  • COHN 1.14
  • ICU N/A
  • Revenue
  • COHN $133,173,000.00
  • ICU $766,000.00
  • Revenue This Year
  • COHN N/A
  • ICU $754.07
  • Revenue Next Year
  • COHN N/A
  • ICU $100.09
  • P/E Ratio
  • COHN $11.19
  • ICU N/A
  • Revenue Growth
  • COHN 78.63
  • ICU N/A
  • 52 Week Low
  • COHN $6.10
  • ICU $0.31
  • 52 Week High
  • COHN $13.25
  • ICU $6.90
  • Technical
  • Relative Strength Index (RSI)
  • COHN 69.24
  • ICU 53.90
  • Support Level
  • COHN $11.02
  • ICU $0.64
  • Resistance Level
  • COHN $12.89
  • ICU $0.94
  • Average True Range (ATR)
  • COHN 0.66
  • ICU 0.11
  • MACD
  • COHN 0.03
  • ICU 0.01
  • Stochastic Oscillator
  • COHN 88.10
  • ICU 67.13

About COHN Cohen & Company Inc.

Cohen & Co Inc is a United States company that delivers financial services in fixed-income markets. It is focused on small-cap banking institutions and has grown to provide an expanding range of capital markets and asset management services. It has three business segments. The Capital Markets segment, which is the key revenue driver, consists of fixed-income sales, trading, matched book repo financing, new issue placements in corporate and securitized products, and advisory services. The Asset Management segment manages assets within collateralized debt obligations, managed accounts, joint ventures, and investment funds. The Principal Investing segment is comprised of investments to earn return rather than to support trading, matched book repo, or other Capital Markets segment activities.

About ICU SeaStar Medical Holding Corporation

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.

Share on Social Networks: